Abcuro (Series C)

Funding Details
Date Award
May 18, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Founding Year
2012
Company Description
Abcuro is developing therapies for autoimmune diseases and certain cancers by targeting specific immune cells.
Market
Healthcare
Location
Newton, Massachusetts, USA
Coinvestors
NEA, Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital, Sanofi Ventures, Pontifax, Mass General Brigham Ventures, New Leaf Ventures, abrdn, BlackRock, Eurofarma Ventures, Soleus Capital

Links
Back to Home Back to Biotechnology Deals View Funding Announcement